Withania Somnifera Extract Composition for Enhanced Bioavailability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

There is a need for alternative Withania somnifera compositions with improved properties, as existing formulations may not fully leverage the bioactive potential of its constituents.

Innovation Solution

A novel Withania somnifera extract composition is developed, comprising a range of bioactive compounds such as withaferin A, withanoside IV, withanolide A, and others, which can be used in nutraceutical or pharmaceutical compositions, along with a detailed process for preparing the extract.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional extraction methods are used for Withania somnifera, then the extraction process is simple, but the bioavailability and efficacy of the extract are insufficient

Engineering Contradiction:
Improvebioavailability and efficacyVSAvoidextraction process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The extraction process is divided into multiple sequential steps: initial extraction with organic solvent, filtration to remove impurities, concentration of the filtrate, and final drying to obtain the extract. This segmentation allows each step to be optimized independently, improving overall bioavailability while maintaining manageable process complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The extraction process maintains continuous useful action by immediately proceeding from extraction to filtration, then to concentration, and finally to drying without interrupting the flow of the extract. This continuous process prevents degradation of bioactive compounds and maximizes efficacy while streamlining the overall procedure

Inventive Principle:
Principle #20Continuity of useful action

2Adaptability or versatility

If multiple bioactive compounds are included in the composition, then the therapeutic potential is enhanced, but the manufacturing precision requirements increase

Engineering Contradiction:
Improvetherapeutic potentialVSAvoidcomposition standardization
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The method establishes specific parameter ranges for each bioactive compound (withaferin A: 0.1-5%, withaferin B: 0.1-5%, withanone: 0.1-5%, withanolide A: 1-10%, withanolide B: 1-10%, withanoside IV: 1-10%, withanoside V: 1-10%, withanoside VI: 1-10%) to ensure consistent therapeutic potential while simplifying manufacturing quality control through defined specifications

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite extract containing multiple bioactive compounds from Withania somnifera that work synergistically. By standardizing the composition to include specific ranges of these compounds rather than isolating single constituents, the method enhances therapeutic potential while maintaining manageable manufacturing precision through composite standardization

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The novel composition enhances the bioavailability and efficacy of Withania somnifera, offering improved stress management, energy levels, and overall health benefits, as demonstrated by increased withanolide content and enhanced dissolution profiles.

Implementation Method 1

extracting the dry powder obtained in step (b) with an aqueous alcohol solvent followed by filtration to obtain the supernatant and residue

Methodology Applied
Scientific EffectExtraction: Liquid-Liquid Extraction

Implementation Method 2

extracting the dry powder obtained in step (b) with an aqueous alcohol solvent

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 3

subjecting the supernatant obtained in step (c) to distillation to obtain the crude extract

Methodology Applied
Scientific EffectDistillation: Distillation

Implementation Method 4

subjecting the residue obtained in step (c) to hot water extraction followed by filtration and collection of the supernatant

Methodology Applied
Scientific EffectExtraction: Liquid-Liquid Extraction

Implementation Method 5

subjecting the residue obtained in step (c) to hot water extraction

Methodology Applied
Scientific EffectHeating: Heating

Data Source

PatentUS12201641B2Compositions comprising <i>Withania Somnifera </i>extract for mammalian consumption
Publication Date: 2025.01.21 SPECNOVA LLC
  • US12201641B2 patent drawing
  • US12201641B2 patent drawing
  • US12201641B2 patent drawing

AI summary

Provided is a Withania somnifera extract composition contains at least one of withaferin A, withanoside IV, withanoside V, withanoside VI, withanolide A, withanolide B, anaferine, anahygrine, 12-deoxywithastromonolide, sitoindoside X, sitoindoside IX, cuscohygrine, isopelletierine, bracteosin A, bracteosin B, or bracteosin C, or a salt or solvate of any one thereof. Related compositions, methods, and processes are also provided.